Skip to content

Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation

AdhereNce to Cied Implantation GuidELInes: Cardiac rehAbilitation as a Window on Time-dependent Indications: an Observational Prospective Study (ANGELICA).

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05764109
Acronym
ANGELICA
Enrollment
488
Registered
2023-03-10
Start date
2019-09-15
Completion date
2025-01-28
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Left Ventricular Systolic Dysfunction, Myocardial Infarction

Brief summary

There are limited data on how the guideline indications for ICD implantation are applied in clinical practice across Europe. Moreover, the impact of time-dependence of some indications to implantation on the guidelines adherence is still unknown. Objective of the present observational study is the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program.

Detailed description

Current guidelines recommend ICD implantation in patients at high risk of sudden cardiac death with either ischemic or non-ischemic heart disease. However, implantation rate of cardiac implantable electrical devices (CIED), especially ICD, CRT and CRT-D, is lower than expected and do not reflect guideline indications. Several factors may justify the differences in ICD implantation rates across Europe and the gap between daily clinical practice and guidelines: economic restrictions, poor guidelines awareness, especially among referring cardiologists and general practitioners, and different guidelines adherence. The impact of time-dependence of some indications to CIED implantation on the guidelines adherence is still unknown. Objective of the present observational study will be the evaluation of the adherence to the scientific guidelines in patients with a time-dependent indication to ICD/CRT-D implantation admitted to an in-hospital cardiac rehabilitation program. This is a prospective, multicenter, observational study performed in 6 cardiac rehabilitation facilities.

Interventions

None listed

Sponsors

Istituti Clinici Scientifici Maugeri SpA
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Admission to an in-hospital cardiac rehabilitation program because of a recent index event; * Provision of signed and dated informed consent form; * Age ≥ 18 years. * NYHA II-III class at the admittance in the cardiac rehabilitation facility; * LVEF ≤ 40% at echocardiography at the admittance in the cardiac rehabilitation facility; * Presence of a time-dependent indication to an ICD/CRT-D implantation: * \<3 month of optimal medical therapy; * \<40 days from the index myocardial infarction in patients with acute coronary syndrome; * 3 months from the revascularization procedure in patients with surgery; * \<3 months in patients with a de-novo heart failure episode of no ischemic etiology. * Patients who have already received an ICD/CRT-D for primary prevention before the admittance in the cardiac rehabilitation facility, despite a time-dependent indication to an ICD/CRT-D implantation; * Indication to ICD-CRT-D implantation for primary prevention.

Exclusion criteria

* Inability to give informed consent (diminished understanding or comprehension); * Age \< 18 years; * NYHA Class I or IV during the cardiac rehabilitation in-hospital stay; * LVEF \> 40% at echocardiography performed at the admittance in the cardiac rehabilitation facility * Absence of a time-dependent indication to an ICD/CRT-D implantation; * Indication to ICD-CRT-D implantation for secondary prevention.

Design outcomes

Primary

MeasureTime frameDescription
Rate of LVEF assessment3 monthsThe evaluation of the rate of patients who will perform an echocardiography for LVEF assessment at the end of the time-window as suggested by the guidelines

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026